Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate.
J Am Chem Soc
; 142(29): 12574-12578, 2020 07 22.
Article
em En
| MEDLINE
| ID: mdl-32574049
(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetonitrile ((S)-CIK) is a key intermediate in the synthesis of (S)-clopidogrel, which is one of the most saleable worldwide antiplatelet and antithrombotic drugs. We show herein a facile method for the direct synthesis of (S)-CIK via Strecker reaction using a homochiral covalent framework catalyst in a heterogeneous way. The asymmetric synthesis involves a photothermal-conversion-triggered, thermally driven reaction which affords (S)-CIK in 98% yield with 94% enantiomeric excess under visible-light irradiation. Furthermore, the above approach is readily extended to a gram-scale level on a fixed-bed continuous-flow model reactor. The potential utility of this strategy is highlighted by the preparation of many more other types of chiral drugs and drug intermediates in a green and facile way.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Acetonitrilas
/
Clopidogrel
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article